About
Magentiq Eye (MAGENTIQ-COLO™) is an AI- and machine-learning-powered colonoscopy assistance platform built specifically for the gastroenterology field. The system processes live colonoscopy video frames in real time, flagging polyps, adenomas, and sessile serrated lesions with high precision and a low false-positive rate—acting as a second reader alongside the endoscopist. Backed by over 65 million tagged frames accumulated over seven years, MAGENTIQ-COLO™ has been validated in one of the largest randomized, blinded, multi-center international trials on AI polyp detection, covering 950+ patients across 10 centers. Results show a 37% relative increase in adenoma per colonoscopy (APC), a 26% relative increase in adenoma detection rate (ADR), and a 48% relative decrease in adenoma miss rate (AMR). The platform is recognized for its superior performance on subtle, low-contrast lesions and its minimal distraction from false positives, making it highly practical in busy clinical environments. Magentiq Eye delivers guaranteed software updates and is designed around a fast-ROI business model for both private clinics and public screening programs. By helping even lower-performing colonoscopists achieve accuracy comparable to top practitioners, it democratizes quality in colorectal cancer prevention—one of the most impactful applications of AI in modern medicine.
Key Features
- Real-Time Polyp Detection: Analyzes live colonoscopy video frame-by-frame to flag polyps, adenomas, and sessile serrated lesions instantly as a second reader for the endoscopist.
- Clinically Validated Performance: Validated in a large-scale multi-center trial across 950+ patients in 10 centers globally, demonstrating a 37% relative increase in APC and a 48% decrease in adenoma miss rate.
- Low False-Positive Rate: Engineered to minimize distracting false positives, especially for subtle, low-contrast lesions, making it highly practical in routine clinical workflows.
- Guaranteed Software Updates: Continuous improvement delivered through guaranteed software updates, ensuring the system's AI models remain current with evolving clinical data.
- Fast ROI Business Model: Designed with a business model that delivers measurable return on investment quickly for both private clinics and public health screening programs.
Use Cases
- Gastroenterologists using real-time AI assistance during colonoscopy to catch subtle polyps they might otherwise miss.
- Hospitals and endoscopy centers seeking to improve their adenoma detection rates and meet quality benchmarks for colorectal cancer screening.
- Public health systems implementing large-scale colorectal cancer screening programs that require consistent diagnostic quality across diverse practitioner skill levels.
- Research institutions conducting clinical studies on AI-assisted endoscopy and polyp detection performance metrics.
- Gastroenterology training programs using AI feedback to help fellows improve their polyp detection technique under supervised conditions.
Pros
- Rigorous Clinical Evidence: One of the most extensively validated AI colonoscopy platforms, with data from 65M+ processed frames and a landmark international multi-center randomized trial.
- Measurable Impact on Patient Outcomes: Demonstrated statistically significant improvements in adenoma detection and miss rate reduction, directly contributing to earlier colorectal cancer prevention.
- High Clinical Usability: Praised by leading gastroenterologists for precision on difficult lesions and low false-positive noise, making it a genuinely useful daily tool rather than a distraction.
- Equalizes Quality Across Practitioners: Brings lower-performing endoscopists up to the accuracy level of top practitioners, enabling consistent quality across entire clinical teams and screening programs.
Cons
- Specialized Medical Use Only: Designed exclusively for gastroenterology/colonoscopy workflows; not a general-purpose AI tool, limiting its applicability to a narrow clinical domain.
- Enterprise Pricing: As a certified medical AI device, pricing is enterprise-level and requires procurement through clinical or institutional channels with no self-serve or trial tier.
- Hardware Integration Requirements: Must be integrated with existing endoscopy hardware and clinical infrastructure, which may require setup effort and coordination with existing equipment vendors.
Frequently Asked Questions
What is MAGENTIQ-COLO™?
MAGENTIQ-COLO™ is the commercial name for Magentiq Eye's AI-assisted colonoscopy product. It uses AI and machine learning to detect polyps and adenomas in real time during colonoscopy procedures, functioning as a second reader for the endoscopist.
How was Magentiq Eye validated?
The system was validated in a large randomized, blinded, international multi-center controlled trial involving more than 950 patients across 10 centers globally. It also draws on over 65 million analyzed and tagged video frames accumulated over seven years of development.
What improvements does it deliver over standard colonoscopy?
Clinical studies show a 37% relative increase in adenoma per colonoscopy (APC), a 26% relative increase in adenoma detection rate (ADR), and a 48% relative decrease in adenoma miss rate (AMR) compared to unassisted colonoscopy.
Is it suitable for both private clinics and public screening programs?
Yes. Magentiq Eye is designed with a fast-ROI business model for private clinics, while also enabling public mass screening programs to guarantee consistent colonoscopy quality across all practitioners—reducing the financial burden of transitioning to large-scale screening.
How does it handle false positives compared to other AI platforms?
Magentiq Eye is specifically engineered to minimize false positives, particularly for subtle, low-contrast lesions. Clinical users have noted it produces fewer distracting false alerts than competing platforms, making it more practical during live procedures.
